Evidence map›Paper›PMID 23869178›Full record

ArticleCancer management and research2013

Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management.

Dinorah Leyva-Illades, Sharon Demorrow

Abstract read
In one paragraph

Article in Cancer management and research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Cannabidiol-Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. GPR55 Receptor Activation by theInternational journal of molecular sciences · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Future Aspects for Cannabinoids in Breast Cancer Therapy.International journal of molecular sciences · 2019
    Review
  15. Article
  16. Review
  17. BioMed research international · 2018
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dinorah Leyva-IlladesDigestive Disease Research Center, Scott and White Hospital, Temple, TX, USA ; Department of Internal MedicineTexas A&M Health Science Center, Temple, TX, USA ; Research Service, Central Texas Veterans Health Care System, Temple, TX, USA.
Sharon Demorrow

Funding

Endocannabinoid Regulation of Cholangiocarcinoma Cell GrowthK01DK078532 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DEMORROW, SHARON · 2007 to 2011
$697k
The Role of Progranulin in Cholangiocarcinoma GrowthR03DK088012 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DEMORROW, SHARON · 2010 to 2011
$134k
NIDDK NIH HHS K01 DK078532NIDDK NIH HHS R03 DK088012
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) modulate a vast array of cellular processes. The current review gives an overview of the general characteristics of GPCRs and their role in physiological conditions. In addition, it describes the current knowledge of the physiological and pathophysiological functions of GPR55, an orphan GPCR, and how it can be exploited as a therapeutic target to combat various cancers.

Indexed as

cancerendocannabinoidsGPCRGPR55

Identifiers

PMID23869178
PMCPMC3706254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.